NDC 24208-040-41 - Xipere
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 24208-040
- Requested NDC
- 24208-040-41
- Package NDCs from labels
- 24208-040-41, 24208-040-40, 24208-040-02, 24208-040-01
- Manufacturer
- Bausch & Lomb Incorporated | Alcami Carolinas Corporation
- Effective date
- 2025-10-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Xipere - Bausch & Lomb Incorporated | Alcami Carolinas Corporation | Bausch & Lomb Incorporated | Alcami Carolinas Corporation | 2025-10-08 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 24208-040-01 | Xipere | 1 in 1 CARTON | INJECTION, SUSPENSION | 1 | 7 | |
| 24208-040-01 | Xipere | 1 in 1 TRAY | INJECTION, SUSPENSION | 1 | 7 | |
| 24208-040-02 | Xipere | 0.9 mL in 1 VIAL | INJECTION, SUSPENSION | 0.9 | 7 | |
| 24208-040-40 | Xipere | 1 in 1 CARTON | INJECTION, SUSPENSION | 1 | 7 | |
| 24208-040-40 | Xipere | 1 in 1 TRAY | INJECTION, SUSPENSION | 1 | 7 | |
| 24208-040-41 | Xipere | 0.9 mL in 1 VIAL | INJECTION, SUSPENSION | 0.9 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 24208-040-40 | ML - Milliliter | 24208-040 | da6c08ed-251c-4030-bfaf-2d7e536d5c98 | 1 | 2023-01-09 |
| 24208-040-41 | ML - Milliliter | 24208-040 | 676b47a3-48f2-4885-932c-12f0b33f42bd | 1 | 2023-04-07 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Potassium Chloride Extended-release | POTASSIUM CHLORIDE EXTENDED-RELEASE | Granules Pharmaceuticals Inc. | b3d4d5b5-2898-ae3d-e053-2a95a90a6d04 | 2025-09-30 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Granules Pharmaceuticals Inc | c1f4832d-4d5c-8c49-e053-2a95a90ac9fe | 2025-09-30 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Bryant Ranch Prepack | 0e875691-7372-46ac-80a1-946e08b40061 | 2025-09-30 | Warnings, Adverse reactions | 660YQ98I10 |
| Xpect Eyewash | EYEWASH | Cintas Corporation | 1d69365d-662b-4248-8fa9-1629451b549a | 2025-09-30 | Warnings | 059QF0KO0R |
| CheBoho TEA TREE ACNE | CHEBOHO TEA TREE ACNE | Opalshi(Guangzhou)E-commerce Co. Ltd. | 3fc4cf84-b2da-c593-e063-6394a90abc5c | 2025-09-27 | Warnings | 059QF0KO0R |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% | Encube Ethicals, Inc. | a20baaac-002d-40ac-9c7b-f92e8ee987ea | 2025-09-25 | Adverse reactions | F446C597KA |
| Potassium Chloride | POTASSIUM CHLORIDE | Epic Pharma, LLC | 00615fad-ad3b-46e8-a89d-48290d937ae2 | 2025-09-23 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Macleods Pharmaceuticals Limited | 89d827c8-91af-4bfd-a846-62e55824e983 | 2025-09-22 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Major Pharmaceuticals | a9d68a40-75e3-4c5c-b5d7-1d6160527fa7 | 2025-09-22 | Warnings, Adverse reactions | 660YQ98I10 |
| Sterile Water | WATER | ProPharma Distribution | 3f2ae880-852f-b45d-e063-6394a90aa1cc | 2025-09-19 | Warnings, Adverse reactions | 059QF0KO0R |
| Jet Lag | ECHINACEA, ALUMINA, ARALIA QUINQUEFOLIA, ARGENTUM, ARNICA MONTANA, ARSENICUM ALBUM, BAPTISIA TINCTORIA, BRYONIA, CANTHARIS, CHELIDONIUM MAJUS, CONIUM MACULATUM, GELSEMIUM SEMPERVIRENS, IODIUM, KALI CARBONICUM, KALI IODATUM, LYCOPODIUM CLAVATUM, LYCOPUS VIRGINICUS, NATRUM MURIATICUM, NUX VOMICA, PHOSPHORUS, PHYTOLACCA DECANDRA, PULSATILLA, RHUS TOXICODENDRON, SABAL SERRULATA, THYROIDINUM. | Newton Laboratories, Inc. | 9c21c935-4ebc-1efd-e053-2995a90aa156 | 2025-09-18 | Warnings | 451W47IQ8X |
| Potassium Chloride | POTASSIUM CHLORIDE | NCS HealthCare of KY, LLC dba Vangard Labs | 542e16b0-44db-490f-b44e-4c88a6e3d8b8 | 2025-09-17 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Strides Pharma Science Limited | 0224e5b3-3c49-4e6e-aa78-1abcc6969246 | 2025-09-17 | Warnings, Adverse reactions | 660YQ98I10 |
| Calcium Chloride | CALCIUM CHLORIDE | ProPharma Distribution | 3eef0115-26f6-2abe-e063-6294a90aa289 | 2025-09-16 | Adverse reactions | M4I0D6VV5M |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | Sun Pharmaceutical Industries, Inc. | b353c8b1-9088-4969-8199-37876f2461cc | 2025-09-15 | Adverse reactions | F446C597KA |
| Triamcinolone Acetonide | TRIAMCINOLONE ACETONIDE | ProPharma Distribution | 3edd3ad8-2561-59b5-e063-6294a90a0165 | 2025-09-15 | Warnings, Adverse reactions | F446C597KA |
| Perikabiven | DEXTROSE, SOYBEAN OIL, ELECTROLYTES, LYSINE, PHENYLALANINE, LEUCINE, VALINE, THREONINE, METHIONINE, ISOLEUCINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, HISTIDINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE | Fresenius Kabi USA, LLC | c2eb5522-8572-45f4-869d-42f9fd251bb6 | 2025-09-15 | Warnings, Adverse reactions | 660YQ98I10 M4I0D6VV5M 4550K0SC9B |
| REFRESH OPTIVE Drops | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | 80275190-d717-40ea-905b-5c8fbe986eac | 2025-09-15 | Warnings | K679OBS311 |
| Refresh Relieva PF Xtra | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | b51b8a75-8faa-430f-8f7e-ee58d3d13f2e | 2025-09-15 | Warnings | K679OBS311 |
| Refresh Relieva | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | Allergan, Inc. | 6b984fa2-4187-45ef-b7d3-15e720abc667 | 2025-09-15 | Warnings | K679OBS311 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.